By Denise Mann HealthDay ReporterFRIDAY, July 25, 2025 (HealthDay News) — Keurig K-Cups are being recalled nationwide due to a packaging issue that could cause ink to run into the coffee during brewing.The U.S. Food and Drug Administration (FDA) issued a voluntary recall of New Mexico Piñon Coffee‘s Dark Pinon Single Serve …
Read More »Increase Seen in Reports of Lidocaine Poisonings and Mortality Since 2010
Following publication of advisories, reports of local anesthetic poisoning decreased, but reports of lidocaine poisoning and mortality increased
Read More »Consensus Offers Best Practices for Post-COVID-19 Residual Abnormalities on Chest CT
Term 'post-COVID-19 residual lung abnormality' should be used instead of 'interstitial lung abnormality' for describing post-COVID-19 abnormalities
Read More »Adherence to Healthy Lifestyle Linked to Lower Risk for Overactive Bladder
Each additional healthy lifestyle factor associated with 17 percent lower risk for overactive bladder
Read More »Random Forest AI Model Superior for Inpatient Mortality Prognostication in Cirrhosis
Model was significantly better than parametric logistic regression and LASSO models for predicting inpatient mortality
Read More »Inflammation and Nutrition-Based Scores Tied to Prognosis of Low-Risk Myelodysplastic Syndrome
Low Prognostic Nutritional Index and high systemic oxidative stress score independently associated with poorer prognosis
Read More »GLP-1 Receptor Agonist Use Linked to Lower Mortality in Seniors With Cancer, T2D
No difference in mortality risk seen for GLP-1 RA and SGLT2i users; significantly lower risk seen for GLP-1 RA versus DPP4i users
Read More »A-Fib Linked to Worse Outcomes for Patients With Heart Failure, MR Undergoing Valve Repair
Increase in primary end point of death, heart failure hospitalization seen in association with baseline AF for patients undergoing M-TEER
Read More »Guselkumab Efficacious for Moderately to Severely Active Crohn Disease in Adults
Both guselkumab regimens superior to placebo
Read More »FDA Upgrades Recall on 160,000+ Bottles of Thyroid Medication
By Denise Mann HealthDay ReporterTHURSDAY, July 24, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has upgraded a recall of a commonly prescribed thyroid medication due to what it described as “subpotent” active ingredients.The recall of more than 160,000 bottles of levothyroxine sodium, which went into effect …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.